|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/20 | |
| A61K 9/28 | |||
| A61K 31/437 |
| (11) | Number of the document | 3294270 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17712970.7 |
| Date of filing the European patent application | 2017-03-22 | |
| (97) | Date of publication of the European application | 2018-03-21 |
| (45) | Date of publication and mention of the grant of the patent | 2018-09-12 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2017/056797 |
| Date | 2017-03-22 |
| (87) | Number | WO 2017/162725 |
| Date | 2017-09-28 |
| (30) | Number | Date | Country code |
| 16162415 | 2016-03-24 | EP |
| (72) |
RANEBURGER, Johannes, AT
|
| (73) |
Sandoz AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | PHARMACEUTICAL COMPOSITION CONTAINING RIFAXIMIN ALPHA&DELTA |
| PHARMACEUTICAL COMPOSITION CONTAINING RIFAXIMIN ALPHA&DELTA |